Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome

Clinical trial NCT00065390 · COMPLETED

Trial details

NCT number: NCT00065390
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Disease Lymphatic Disease Lymphoproliferative Disorder

Start date: 2003-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.